Wells Fargo & Company Foghorn Therapeutics Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 11,883 shares of FHTX stock, worth $93,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,883

Previous 9,272 28.16%

Holding current value

$93,162

Previous $53,000 107.55%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.8 - $9.99 $12,532 - $26,083	2,611 Added 28.16%	11,883 $110,000
Q2 2024 Aug 13, 2024	BUY	$5.05 - $8.0 $16,124 - $25,544	3,193 Added 52.53%	9,272 $53,000
Q1 2024 May 10, 2024	BUY	$2.82 - $7.94 $2,292 - $6,455	813 Added 15.44%	6,079 $40,000
Q4 2023 Feb 09, 2024	BUY	$2.94 - $6.76 $3,528 - $8,112	1,200 Added 29.51%	5,266 $33,000
Q3 2023 Nov 13, 2023	SELL	$5.0 - $9.87 $22,080 - $43,585	-4,416 Reduced 52.06%	4,066 $20,000
Q2 2023 Aug 15, 2023	SELL	$5.37 - $8.84 $4,242 - $6,983	-790 Reduced 8.52%	8,482 $59,000
Q1 2023 May 12, 2023	BUY	$4.66 - $8.99 $18,094 - $34,908	3,883 Added 72.05%	9,272 $57,000
Q4 2022 Feb 13, 2023	BUY	$5.44 - $9.46 $27,319 - $47,508	5,022 Added 1368.39%	5,389 $34,000
Q3 2022 Nov 14, 2022	SELL	$7.52 - $18.01 $1,466 - $3,511	-195 Reduced 34.7%	367 $3,000
Q2 2022 Aug 12, 2022	SELL	$8.48 - $16.84 $30,053 - $59,680	-3,544 Reduced 86.31%	562 $8,000
Q1 2022 May 16, 2022	SELL	$8.87 - $22.1 $60,386 - $150,456	-6,808 Reduced 62.38%	4,106 $63,000
Q4 2021 Feb 14, 2022	BUY	$10.79 - $22.87 $117,762 - $249,603	10,914 New	10,914 $250,000
Q3 2021 Nov 15, 2021	SELL	$8.33 - $15.02 $316 - $570	-38 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.32 - $13.26 $20,625 - $29,344	-2,213 Reduced 98.31%	38 $0
Q1 2021 May 13, 2021	SELL	$11.8 - $23.11 $17,652 - $34,572	-1,496 Reduced 39.93%	2,251 $30,000
Q4 2020 Feb 09, 2021	BUY	$15.12 - $25.88 $56,654 - $96,972	3,747 New	3,747 $76,000

Others Institutions Holding FHTX

# of Institutions

Shares Held

33.3M

Call Options Held

8.7K

Put Options Held

2.4K

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $326M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Foghorn Therapeutics Inc. Transaction History